Quick Answer
Organogenesis Holdings Inc. reported Total Assets of $598.73 million for the year ending 2025.
- Organogenesis Holdings Inc. showed an increase of +20.3% in Total Assets from 2024 to 2025.
- This data is from Organogenesis Holdings Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $821.9 thousand | Q1 2017: $311.24 million | Q2 2017: $311.56 million | Q3 2017: $312.06 million | Q1 2018: $313.79 million | Q2 2018: $314.98 million | Q3 2018: $316.31 million | Q1 2019: $176.45 million | Q2 2019: $168.07 million | Q3 2019: $174.64 million | Q1 2020: $208.34 million | Q2 2020: $216.49 million | Q3 2020: $246.43 million | Q1 2021: $319.18 million | Q2 2021: $355.56 million | Q3 2021: $370.42 million | Q1 2022: $436.27 million | Q2 2022: $456.36 million | Q3 2022: $457.27 million | Q1 2023: $446.11 million | Q2 2023: $450.31 million | Q3 2023: $462.65 million | Q1 2024: $458.48 million | Q2 2024: $443.16 million | Q3 2024: $446.30 million | Q1 2025: $467.39 million | Q2 2025: $461.13 million | Q3 2025: $509.83 million.
- Over the full 11 years of available data (2015 to 2025), Organogenesis Holdings Inc.'s Total Assets has grown by 143,731.8%.
- Historical annual values: Fiscal year 2025: $598.73 million | Fiscal year 2024: $497.89 million | Fiscal year 2023: $460.03 million | Fiscal year 2022: $449.36 million | Fiscal year 2021: $443.26 million | Fiscal year 2020: $290.22 million | Fiscal year 2019: $220.69 million | Fiscal year 2018: $163.68 million | Fiscal year 2017: $148.72 million | Fiscal year 2016: $311.44 million | Fiscal year 2015: $416.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: